Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,058 | 150,091 | 193,551 | 178,581 | 191,442 |
| Marketable Securities | 88,916 | 89,184 | 88,506 | N/A | 9,952 |
| Receivables | 2,368 | 691 | 305 | 11 | 64 |
| Other current assets | 2,297 | 3,809 | 4,287 | 3,961 | 2,561 |
| TOTAL | $232,756 | $253,612 | $296,994 | $193,275 | $215,339 |
| Non-Current Assets | |||||
| PPE Net | 3,909 | 4,333 | 4,770 | 5,278 | 5,823 |
| Investments And Advances | 29,824 | 29,952 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,066 | 5,422 | 5,993 | 6,629 | 7,180 |
| TOTAL | $38,799 | $39,707 | $10,763 | $11,907 | $13,003 |
| Total Assets | $271,555 | $293,319 | $307,757 | $205,182 | $228,342 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,498 | 2,485 | 3,945 | 2,102 | 1,695 |
| Accrued Expenses | 18,567 | 15,768 | 14,500 | 12,570 | 13,815 |
| TOTAL | $40,056 | $49,865 | $44,496 | $35,590 | $30,819 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,991 | 31,612 | 26,051 | 20,918 | 15,309 |
| Other Non-Current Liabilities | 2,478 | 3,050 | 3,606 | 4,208 | 4,884 |
| TOTAL | $2,478 | $11,341 | $20,552 | $29,250 | $37,958 |
| Total Liabilities | $42,534 | $61,206 | $65,048 | $64,840 | $68,777 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,078 | 52,967 | 52,648 | 52,120 | 46,304 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -490,830 | -480,348 | -453,918 | -428,223 | -401,849 |
| Other shareholders' equity | -151 | 166 | -15 | 0 | -24 |
| TOTAL | $229,021 | $232,113 | $242,709 | $140,342 | $159,565 |
| Total Liabilities And Equity | $271,555 | $293,319 | $307,757 | $205,182 | $228,342 |